Sinopsis
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episodios
-
![Episode 135: The ULTIMATE Trial]()
Episode 135: The ULTIMATE Trial
22/12/2021 Duración: 05minJunjie Zhang and C. Michael Gibson discuss 3-year outcomes after IVUS- versus angiography-guided DES implantation.
-
![Episode 134: The PROSPECT ABSORB Trial]()
Episode 134: The PROSPECT ABSORB Trial
08/12/2021 Duración: 12minGregg Stone and C. Michael Gibson discuss a randomized trial examining interventional treatment of vulnerable plaques.
-
![Episode 133: The COBRA-REDUCE Trial]()
Episode 133: The COBRA-REDUCE Trial
02/12/2021 Duración: 09minRobert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.
-
![Episode 132: The RIVER Trial]()
Episode 132: The RIVER Trial
10/11/2021 Duración: 08minOtavio Berwanger and C. Michael Gibson discuss rivaroxaban versus warfarin in patients with bioprosthetic mitral valves and atrial fibrillation or flutter.
-
![Episode 131: The SCOPE II Trial]()
Episode 131: The SCOPE II Trial
03/11/2021 Duración: 10minCorrado Tamburino and C. Michael Gibson discuss a randomized trial of two self-expanding TAVR bioprostheses.
-
![Episode 130: The DISRUPT CAD III Trial]()
Episode 130: The DISRUPT CAD III Trial
20/10/2021 Duración: 17minDean Kereiakes and C. Michael Gibson discuss intravascular lithotripsy for the treatment of severe coronary calcification.
-
![Episode 129: The TICO-STEMI Trial]()
Episode 129: The TICO-STEMI Trial
06/10/2021 Duración: 08minByeong-Keuk Kim and C. Michael Gibson discuss a randomized trial of ticagrelor monotherapy versus ticagrelor with aspirin in STEMI.
-
![Episode 128: The COMPARE CRUSH Trial]()
Episode 128: The COMPARE CRUSH Trial
22/09/2021 Duración: 09minGeorgios Vlachojannis and C. Michael Gibson discuss a randomized trial of prehospital crushed versus uncrushed prasugrel in STEMI.
-
![Episode 127: The SOLOIST-WHF and SCORED Trials]()
Episode 127: The SOLOIST-WHF and SCORED Trials
08/09/2021 Duración: 16minDeepak Bhatt and C. Michael Gibson discuss data on sotagliflozin in diabetes.
-
![Episode 126: The REFLECT II Trial]()
Episode 126: The REFLECT II Trial
25/08/2021 Duración: 08minJeffrey Moses and C. Michael Gibson discuss a randomized trial of cerebral embolic protection during TAVR.
-
![Episode 125: The TIPS-3 Trial]()
Episode 125: The TIPS-3 Trial
18/08/2021 Duración: 09minSalim Yusuf and C. Michael Gibson discuss aspirin alone and in combination with a polypill for CVD primary prevention.
-
![Episode 124: The MITHRAS Trial]()
Episode 124: The MITHRAS Trial
04/08/2021 Duración: 03minPhilipp Lurz and C. Michael Gibson discuss a randomized trial of ASD closure after TMVr.
-
![Episode 123: The XIENCE 90/28 Trial]()
Episode 123: The XIENCE 90/28 Trial
21/07/2021 Duración: 10minRoxana Mehran and C. Michael Gibson discuss 3-month and 1-month DAPT after everolimus-eluting stents in high-bleeding-risk patients.
-
![Episode 122: The MSTOPS Trial]()
Episode 122: The MSTOPS Trial
07/07/2021 Duración: 06minSteven Steinhubl and C. Michael Gibson discuss 3-year outcomes in a nationwide, randomized, pragmatic clinical trial of A-fib screening.
-
![Episode 121: The TARGET FFR Trial]()
Episode 121: The TARGET FFR Trial
23/06/2021 Duración: 08minDamien Collison and C. Michael Gibson discuss a randomized trial of physiology-guided PCI optimization.
-
![Episode 120: The STRENGTH Trial]()
Episode 120: The STRENGTH Trial
16/06/2021 Duración: 11minA. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.
-
![Episode 119: The STRENGTH Trial]()
Episode 119: The STRENGTH Trial
02/06/2021 Duración: 11minA. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.
-
![Episode 118: The OPTIMIZE Trial]()
Episode 118: The OPTIMIZE Trial
19/05/2021 Duración: 10minDean Kereiakes and C. MIchael Gibson discuss a randomized trial of a novel, ultra-low-profile fixed-wire DES.
-
![Episode 117: The AHA COVID-19 CVD Registry]()
Episode 117: The AHA COVID-19 CVD Registry
06/05/2021 Duración: 15minRobert Harrington and C. Michael Gibson discuss the registry's design, implementation, and initial results.
-
![Episode 116: The TANGO Trial]()
Episode 116: The TANGO Trial
21/04/2021 Duración: 06minEhrin Armstrong and C. Michael Gibson discuss a randomized, dose-escalation trial of temsirolimus adventitial delivery below the knee.
